Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Maraviroc on Endothelial Function in HIV-Infected Patients
NCT00844519Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cardiovascular disease (CVD) and inflammation comparing Maraviroc with Placebo (2 arms). Primary endpoint: Flow-Mediated Dilation at 24 weeks. Started Jan 2010; status: completed.
02
Drugs
maraviroc
03
Conditions
cardiovascular disease (CVD)inflammation
Beyond the preview
Go deeper on NCT00844519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844519.